Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 231 - 240 of 397

Selected Filters:
17 November 2022

Prevalence of HIV PrEP Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use

This article from the Journal of the American Medical Association (JAMA) estimates HIV PrEP uptake among commercially insured persons with opioid or stimulant use disorder by injection drug use status in the USA.

Research, Service Delivery

External Link
15 November 2022

Results from a Safety Study of the Dapivirine Vaginal Ring and Oral PrEP in Breastfeeding Mother-Infant Pairs

This poster from AIDS 2022 presents results from the MTN-043/B-Protected trial, comparing the safety profile of the dapivirine vaginal ring against oral PrEP use during breastfeeding.

Research

Document
14 November 2022

Uptake and Use of Oral PrEP among Heterosexual Men: Results and lessons from a pilot study in Johannesburg, South Africa

Although most PrEP strategies and programs have focused on other populations, formative research conducted by the Mpilo Project in South Africa found that PrEP may also be beneficial and appealing to a substantial segment of heterosexual men. From August 2021 to July 2022 the project implemented a pilot study providing PrEP to 564 men, free…

Research, Service Delivery

Event
11 November 2022

PMM Landscape Analysis, Malawi & Zimbabwe (2020)

PMM is advancing planning for future biomedical prevention product introductions, with a focus on CAB-LA, to avoid oral PrEP challenges and reduce time to impact. PMM used quantitative and qualitative methods to identify sub-national geographies, target populations, delivery channels, and prevention networks to prioritize in early introduction activities for CAB-LA.

Research, Service Delivery

Document
11 November 2022

The Global Men and HIV Technical Working Group (MENHT) Webinar Series -Episode #5 – Men and PrEP

Global data shows that men living with HIV, in all their diversity, are less likely than women to know their HIV status, less likely to initiate ART, less likely to remain engaged in care, and less likely to be virally suppressed. Oral PrEP is recommended under one of the five key HIV prevention pillars and…

Demand Creation/Marketing, Research

Event
10 November 2022

Relative Cost-effectiveness of Long-acting Injectable Cabotegravir versus Oral Pre-exposure Prophylaxis in South Africa based on the HPTN 083 and HPTN 084 Trials: A modelled economic evaluation and threshold analysis

This article from The Lancet HIV estimates the incremental cost-effectiveness of long-acting injectable cabotegravir (CAB for PrEP) compared with tenofovir disoproxil fumarate and emtricitabine (TDF/FTC oral PrEP) in South Africa, using methods standard to government planning, and determines the threshold price at which CAB for PrEP is as cost-effective as TDF/FTC oral PrEP.

Financing & Costing, Research

External Link
10 November 2022

Examining Provincial PrEP Coverage and Characterizing PrEP Awareness and Use among Gay, Bisexual and Other Men who Have Sex with Men in Vancouver, Toronto and Montreal, 2017–2020

This article from Journal of the International AIDS Society examines differences over time in PrEP uptake and assessed factors associated with PrEP awareness and use in gay and bisexual men who have sex with men in Montreal, Toronto, and Vancouver, Canada.

Research

External Link
10 November 2022

Using Nominal Group Technique to Identify Barriers and Facilitators to Preventing HIV Using Combination Same-day Pre-exposure Prophylaxis and Medications for Opioid Use Disorder

This article from Harm Reduction Journal identifies barriers and facilitators to integrating PrEP services with provision of medications for opioid use disorder for people who use drugs in New Haven, Connecticut, USA.

Research

External Link
10 November 2022

Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria

This article from Global Health: Science and Practice investigates the willingness of gay and bisexual men who have sex with men, female sex workers, and people who use drugs to use and pay for HIV prevention commodities to support improved sustainable HIV prevention programming.

Financing & Costing, Research

External Link
10 November 2022

Bottlenecks and Solutions During Implementation of the DREAMS Program for Adolescent Girls and Young Women in Namibia

This article from Global Health: Science and Practice synthesizes implementation bottlenecks experienced while implementing the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) program, an HIV prevention intervention for adolescent girls and young women (AGYW) in Namibia from 2017 to 2019, highlighting practical implementation issues and higher-level considerations for AGYW-centered HIV prevention programs.

Research

External Link